Phase II study of high-dose cisplatin, e
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer
✍
J.M. Cain; C. Collins; S. Petersdorf; D.C. Figge; H.K. Tamimi; B.E. Greer; R.B.
📂
Article
📅
1996
🏛
Elsevier Science
🌐
English
⚖ 688 KB